Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: Recent developments

Brain Res. 2017 Jun 15:1665:1-21. doi: 10.1016/j.brainres.2017.03.029. Epub 2017 Apr 7.

Abstract

Neuronal cell injury, as a consequence of acute or chronic neurological trauma, is a significant cause of mortality around the world. On a molecular level, the condition is characterized by widespread cell death and poor regeneration, which can result in severe morbidity in survivors. Potential therapeutics are of major interest, with a promising candidate being brain-derived neurotrophic factor (BDNF), a ubiquitous agent in the brain which has been associated with neural development and may facilitate protective and regenerative effects following injury. This review summarizes the available information on the potential benefits of BDNF and the molecular mechanisms involved in several pathological conditions, including hypoxic brain injury, stroke, Alzheimer's disease and Parkinson's disease. It further explores the methods in which BDNF can be applied in clinical and therapeutic settings, and the potential challenges to overcome.

Keywords: Brain injury; Brain-derived neurotrophic factor; Neuroprotection.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / therapy
  • Animals
  • Brain / metabolism*
  • Brain-Derived Neurotrophic Factor / metabolism*
  • Humans
  • Hypoxia, Brain / metabolism
  • Hypoxia, Brain / therapy
  • Neurons / metabolism*
  • Parkinson Disease / metabolism
  • Parkinson Disease / therapy

Substances

  • Brain-Derived Neurotrophic Factor